Stage-Specific Activity of Pentavalent Antimony against Leishmania donovani Axenic Amastigotes
The standard treatment of human visceral leishmaniasis involves the use of pentavalent antimony (SbV) compounds. In recent years increasing numbers of clinical failures of treatment with SbV have been reported, probably due to the development of parasite resistance to this compound. The mode of acti...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1999
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89063/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9925518/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.2.278 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|